HelpAcademyLoginJoin us as a Member

Competitive landscape

Drugs aimed at the same indication, from approved to preclinical.

2 drugs for “Pompe Disease (Late-onset)”

Phase 3 2

  • AT2221AMICUS THERAPEUTICS, INC.Pompe Disease (Late-onset)
  • ATB200AMICUS THERAPEUTICS, INC.Pompe Disease (Late-onset)

Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.